ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2175

Skin Manifestations of Rheumatic Diseases: Educating Providers to Improve Diagnostic Skills

Brittany Ashe1, Ellen Koch2, Tiffany Yang1 and Kathryn Torok2, 1UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, PA

Meeting: ACR Convergence 2025

Keywords: Access to care, education, medical, skin

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2159–2194) Professional Education Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Among pediatric patients with scleroderma, there is a significant delay between onset of symptoms and diagnosis ranging from 1.2-1.6 years for Localized Scleroderma (LS) to 1.9-2.8 years for Systemic Sclerosis (SSc). Stubbs et al explored caregivers’ perceptions of navigating their child’s diagnosis with LS and SSc: their work identified that the number one barrier parents identified was lack of provider knowledge(1). Our aim is to create an intervention for front-line providers to improve the recognition of rashes associated with rheumatologic disease with the ultimate goal to improve referral patterns and decrease time to diagnosis.

Methods: Using Kern’s Model of curriculum development, we created a needs assessment to evaluate competency among a range of pediatric providers by querying their skills, knowledge, and attitudes surrounding rash identification. We also obtained qualitative data which was coded and used to generate themes to inform the quantitative results.

Results: We received 39 responses (53% resident, 28% attending, 18% APP). Approximately a third were currently practicing or planning to become primary care providers, another third planned to go into subspecialties other than rheumatology, and the remaining third were planning to continue or pursue hospitalist or ED positions. The majority of respondents (61.5%) did not feel they received adequate training in rheumatology during their pre-clinical years. On recall, most reported 5-10 hours of pre-clinical education spent on rheumatology. Regarding skill identifying rashes, the majority of respondents (64%) rated themselves as only slightly knowledgeable, 25.6% as moderate and 10% having no knowledge/skill identifying rheumatic skin disease. Reassuringly, 100% of participants responded that identification of rashes was somewhat important or very important. Additionally, we queried respondents for qualitative responses. Themes that emerged included that rheumatology was frequently taught as an “afterthought”, with inadequate content, and without pediatric-specific examples. Many also identified that their skills identifying rashes were poor because they had little experience.

Conclusion: A needs assessment of front-line pediatricians revealed that there is a lack of knowledge and skill surrounding rheumatic diseases and the common rashes that can provide clues to their diagnosis. More education is needed to ensure that providers are familiar with these rare diagnoses to facilitate early and appropriate rheumatology referral to prevent accumulation of damage with delayed diagnosis. Our group is creating a 45min didactic intervention dedicated to recognizing skin manifestations of key pediatric rheumatic conditions to further address these needs. We will assess efficacy via pre- and post-testing as well as qualitative responses.(1) Stubbs LA, Ferry AM, Guffey D, et al. Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers’ perspectives. Pediatr Rheumatol Online J 2023;21(1):39. DOI: 10.1186/s12969-023-00819-6.

Supporting image 1

Supporting image 2


Disclosures: B. Ashe: None; E. Koch: None; T. Yang: None; K. Torok: None.

To cite this abstract in AMA style:

Ashe B, Koch E, Yang T, Torok K. Skin Manifestations of Rheumatic Diseases: Educating Providers to Improve Diagnostic Skills [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/skin-manifestations-of-rheumatic-diseases-educating-providers-to-improve-diagnostic-skills/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/skin-manifestations-of-rheumatic-diseases-educating-providers-to-improve-diagnostic-skills/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology